No defined human molecular target

The term "No defined human molecular target" refers to a classification used for therapeutic agents that do not interact with a specific, identifiable protein, nucleic acid, or other discrete biomolecule to exert their effects (ChEMBL, 2024). This category typically includes drugs that function through broad physical or chemical mechanisms, such as altering pH, changing osmotic pressure, or acting as adsorbents (FDA, 2023). For example, antacids like magnesium hydroxide neutralize stomach acid through a direct chemical reaction rather than by binding to a receptor (StatPearls, 2023). Similarly, osmotic diuretics like mannitol work by creating an osmotic gradient in the renal tubules to promote water excretion (PubMed, 2022). In pharmacological databases, this designation is also applied to compounds whose specific mechanism of action remains unknown or uncharacterized despite demonstrated clinical efficacy. For biotech analysts, this classification highlights a lack of target-based specificity, which can complicate traditional drug development pipelines focused on structure-activity relationships.

Other names

Unknown targetNon-specific targetUnassigned targetNon-molecular mechanism

Non-specific physical or chemical interactions including pH neutralization, osmotic gradient formation, and physical adsorption.